Chemoradiation is a cancer treatment that delivers chemotherapy and radiation therapy at the same time. Rather than using these treatments separately, combining them makes cancer cells more vulnerable to radiation damage, improving the odds of shrinking or eliminating a tumor. It is the standard approach for several types of locally advanced cancer, including head and neck cancers, cervical cancer, and non-small-cell lung cancer that cannot be surgically removed.
How the Combination Works
Radiation therapy damages cancer cells by breaking apart their DNA. Chemotherapy drugs, when given alongside radiation, act as “radiosensitizers,” meaning they make tumor cells less able to repair that DNA damage. The chemotherapy disrupts the cancer cell’s internal repair machinery, so when radiation breaks the DNA strands, the damage sticks. Some drugs also interfere with where a cell is in its growth cycle, catching it at the most vulnerable phase when radiation hits.
This is why timing matters. When chemotherapy circulates through the body during the same period radiation is being delivered to the tumor, both treatments hit cancer cells simultaneously from different angles. The radiation causes direct physical damage, while the chemotherapy blocks the cell’s ability to bounce back. The result is more cancer cell death than either treatment would produce alone.
Concurrent vs. Sequential Treatment
There are two main ways to combine chemotherapy and radiation. In concurrent chemoradiation, both treatments happen during the same weeks. In sequential treatment, one finishes before the other begins. For most cancers where chemoradiation is recommended, the concurrent approach produces better outcomes.
A major clinical trial for stage III non-small-cell lung cancer found that five-year survival was 16% with concurrent chemoradiation compared to 10% with sequential treatment. A separate Japanese trial confirmed similar results: median survival reached 17 months with concurrent treatment versus 13 months with sequential. The tradeoff is that concurrent treatment tends to cause more intense short-term side effects, since the body is absorbing both therapies at once.
Cancers Commonly Treated With Chemoradiation
Chemoradiation is a standard treatment for locally advanced cancers, meaning tumors that have grown into nearby tissue or lymph nodes but haven’t spread to distant organs. The most common cancers treated this way include:
- Head and neck cancers: Often treated with radiation delivered in 35 daily sessions over seven weeks, paired with a platinum-based chemotherapy drug given either weekly or every three weeks.
- Cervical cancer: Concurrent chemoradiation replaced radiation alone as the standard of care after trials showed significantly better tumor control.
- Non-small-cell lung cancer: For patients with unresectable stage III disease and good overall health, concurrent chemoradiation is the recommended first-line treatment.
- Rectal and anal cancers: Chemoradiation is frequently used before surgery to shrink tumors, sometimes enough to allow less invasive procedures.
The specific chemotherapy drugs vary by cancer type. Platinum-based drugs like cisplatin and carboplatin are the most widely used because they are effective radiosensitizers. Taxane-based drugs are also common. The choice depends on which drug offers the best tumor-killing effect with the lowest toxicity for a given cancer.
What Treatment Looks Like Day to Day
A typical course of chemoradiation lasts five to seven weeks. Radiation is usually delivered once a day, five days a week, with each session lasting only minutes. Chemotherapy is given on a separate schedule layered on top, either as an infusion once a week or in larger doses every three weeks. For head and neck cancers, about 60% of patients receive weekly chemotherapy doses, while 40% receive larger doses spaced three weeks apart.
Before treatment begins, there is a planning phase. A radiation oncologist maps the exact area to be treated using imaging scans, and a custom treatment plan is designed to target the tumor while sparing as much healthy tissue as possible. For head and neck cancers, a fitted mask holds the head in the same position for every session.
Preparing Before Treatment Starts
Preparation depends on the cancer’s location, but a few steps are common. The National Cancer Institute recommends seeing a dentist at least four weeks before starting treatment, especially for head and neck cancers. This allows time to address any dental problems and heal before therapy begins, since treatment can make the mouth more vulnerable to infection and slow healing. Maintaining thorough oral hygiene before and throughout treatment helps reduce the severity of mouth-related side effects.
Nutritional preparation is also important. Some patients receiving chemoradiation for head and neck or esophageal cancers may have a feeding tube placed before treatment starts, since swallowing can become painful as treatment progresses. A dietitian often joins the care team early to help maintain weight and energy levels throughout the course.
Side Effects During Treatment
Because chemoradiation hits harder than either therapy alone, side effects tend to be more pronounced. They fall into two categories: effects from the radiation (which are localized to the treatment area) and effects from the chemotherapy (which are systemic, affecting the whole body).
Radiation side effects depend on where the beam is aimed. For pelvic cancers like cervical cancer, bowel irritation occurs in roughly 61% of patients, urinary symptoms in 27%, and skin reactions in 27%. For head and neck cancers, sore throat, mouth sores, dry mouth, and difficulty swallowing are common and tend to worsen as weeks go on.
Adding chemotherapy to radiation increases certain systemic side effects. Drops in blood cell counts (which raise infection risk) occur in 5% to 37% of patients depending on the regimen. Nausea and vomiting affect about 12% to 14%. Fatigue builds over the course of treatment and often peaks in the final weeks.
Most acute side effects improve within a few weeks after treatment ends. Research on cervical cancer patients has found that adding chemotherapy to radiation does not appear to increase the rate of long-term complications, which is reassuring given how much more effective the combined approach is. Long-term effects from radiation itself can include changes in bowel or bladder function, depending on the treatment site.
Before Surgery, After Surgery, or Instead of Surgery
Chemoradiation serves different goals depending on when it is used relative to surgery. When given before surgery (called neoadjuvant treatment), the aim is to shrink a tumor so it becomes easier to remove, or to make a patient eligible for a less extensive operation. In breast and rectal cancers, this approach can sometimes preserve more healthy tissue and allow organ-sparing procedures.
When given after surgery (adjuvant treatment), the goal is to eliminate any microscopic cancer cells left behind and reduce the chance of the cancer returning. In some cases, particularly with head and neck cancers and cervical cancer, chemoradiation is used as the primary treatment with no surgery planned at all. This is called definitive chemoradiation, and the intent is to cure the cancer using the combined therapy alone.